Articles

Immunotherapy against a major autoantigen in type 1 diabetes may preserve beta-cell function early after disease onset but not reverse the process, researchers said.

Combination therapy with GLP-1 and gastrin restores normoglycemia.

After 10 year follow-up of those Type 2 patients in the UKPDS who received intensive glucose therapy, they found less microvascular complications.

Weight gain in early life predicts risk of islet autoimmunity in children with a first degree relative with type 1 diabetes.

Strengthening patients’ self-efficacy may improve the control of HbA1c and may result in a decrease of ethnic differences in outcomes.

Prozac (fluoxetine), can amplify ANS and metabolic counterregulatory mechanisms during moderate hypoglycemia in patients with type 1 diabetes.

The US Department of Health and Human Services (HHS) has issued guidelines regarding the types and amounts of physical activity that provide substantial health benefits for physical activity for individuals 6 years and older.

Scientists at Edinburgh University yesterday revealed they have moved a step closer to a cure for diabetes, thanks to groundbreaking stem-cell research.

Researchers have identified a particular subset of cells that are linked to obesity-associated insulin resistance, and that offer a promising new target for the treatment of diabetes.

Physicians need to aggressively treat high blood pressure as soon as it develops in patients with diabetes if they are to effectively lower the 7-fold higher mortality rate observed in patients with both conditions.